GENEVAC-B (Hepatitis B Vaccine (rDNA) I.P.)

GENEVAC-B (Hepatitis B Vaccine (rDNA) I.P.)

Hepatitis B vaccine is indicated for active immunization against Hepatitis B infection in subjects considered at risk of exposure to HBV positive material.

INDICATION

Hepatitis B vaccine is indicated for active immunization against Hepatitis B infection in subjects considered at risk of exposure to HBV positive material.

ROUTE OF ADMINISTRATION

Intramuscular Injection.

IMMUNIZATION SCHEDULE

Pediatric dose vaccine: 10 mcg dose (in 0.5 ml suspension) is recommended for neonates, infants, children and adolescents upto 19 years of age.

Adult dose vaccine: 20 mcg dose (1.0 ml suspension) is recommended for adults aged 20 years and above

  • A series of 3 shots can prevent this serious disease
  • 6, 10, 14 weeks for infants
  • 0, 1, 6 months for children, adolescents and adults
  • 0, 1, 2 months (for rapid protection)

COMPOSITION

  • Each ml dose contains
  • Purified Hepatitis-B surface antigen 20 mcg
  • Adsorbed on Aluminium hydroxide, Al+++ ≤ 1.25 mg
  • Preservative: ≤ 0.01% Thiomersal
PRESENTATION:

Box of 10 ampoules of 0.5 ml each
Box of 10 ampoules of 1 ml each
Box of one 10 ml MD vial

Reviews

There are no reviews yet.

Be the first to review “GENEVAC-B (Hepatitis B Vaccine (rDNA) I.P.)”

Your email address will not be published. Required fields are marked *

Top